Grant: Project Grant
McMaster University
$267,750.00
Benzodiazepine-free cardiac anesthesia for reduction of postoperative delirium in the intensive care unit (B-Free): A multi-centre, randomized, cluster crossover trial
FY 2022-23
Summary
Delirium, a temporary state of brain dysfunction, occurs in 1 in 5 adults after open heart surgery. Although delirium does not last long, patients who experience delirium are at a higher risk of problems that last after delirium is over. These problems include decreases in mobility, self-care, and independent living. Patients with delirium stay longer in hospital, are more likely to go to a nursing home, and are at greater risk of dying.
Benzodiazepines are a sedative medication that may be associated with delirium that are rarely used in the ICU after surgery. However, benzodiazepines are commonly used in the operating room during open heart surgery because of their beneficial effects. These benefits include amnesia and a limited impact on blood pressure, which can be unstable in patients having cardiac surgery. In response to these benefits and risks, practice is divided among cardiac anesthesiologists; some never use benzodiazepines during cardiac surgery and others use them for nearly all patients.
Because the best approach (liberal vs. restricted benzodiazepines) remains uncertain, we are comparing the effect of two hospital policies on postoperative delirium in 20 centres. One policy gives benzodiazepines to most patients during cardiac surgery. The other policy uses alternative medications and no benzodiazepines. Each centre tests the two policies in random sequence during 12 periods of 4 weeks.
Our initial analysis suggests that the changing cardiac surgery population and decrease in cardiac surgery cases during the COVID-19 pandemic have led to a need for additional periods of data collection to fully answer this important question. We have identified 11 of our 20 sites who are able to participate for an additional six periods. This will result in the inclusion of an additional 5000 patients. Answering this important question will help determine the best medications to use for anesthesia during heart surgery to prevent postoperative brain dysfunction.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
469870
Name
Spence Jessica
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Randomized Controlled Trials
Projecttitle
Benzodiazepine-free cardiac anesthesia for reduction of postoperative delirium in the intensive care unit (B-Free): A multi-centre, randomized, cluster crossover trial
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$267,750
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Anesthesia; Cardiac Surgery; Delirium; Randomized Cluster Crossover Trial; Statistics
Abstract
Delirium, a temporary state of brain dysfunction, occurs in 1 in 5 adults after open heart surgery. Although delirium does not last long, patients who experience delirium are at a higher risk of problems that last after delirium is over. These problems include decreases in mobility, self-care, and independent living. Patients with delirium stay longer in hospital, are more likely to go to a nursing home, and are at greater risk of dying.
Benzodiazepines are a sedative medication that may be associated with delirium that are rarely used in the ICU after surgery. However, benzodiazepines are commonly used in the operating room during open heart surgery because of their beneficial effects. These benefits include amnesia and a limited impact on blood pressure, which can be unstable in patients having cardiac surgery. In response to these benefits and risks, practice is divided among cardiac anesthesiologists; some never use benzodiazepines during cardiac surgery and others use them for nearly all patients.
Because the best approach (liberal vs. restricted benzodiazepines) remains uncertain, we are comparing the effect of two hospital policies on postoperative delirium in 20 centres. One policy gives benzodiazepines to most patients during cardiac surgery. The other policy uses alternative medications and no benzodiazepines. Each centre tests the two policies in random sequence during 12 periods of 4 weeks.
Our initial analysis suggests that the changing cardiac surgery population and decrease in cardiac surgery cases during the COVID-19 pandemic have led to a need for additional periods of data collection to fully answer this important question. We have identified 11 of our 20 sites who are able to participate for an additional six periods. This will result in the inclusion of an additional 5000 patients. Answering this important question will help determine the best medications to use for anesthesia during heart surgery to prevent postoperative brain dysfunction.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Spence, Jessica; Connolly, Stuart J; Lee, Shun Fu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $267,750~ $0~